X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

University of Rochester Surveys

u-rochester-tool-imageThe University of Rochester seeks participants for three online studies. All participants will be entered into a lottery; winners will receive a $50 Amazon.com gift certificate.

Visit the Study Website

ProstateTrials@urmc.rochester.edu | 585-275-5973

 

Study 1: Low risk prostate cancer – The study is open to men with newly diagnosed low risk prostate cancer. Participation in the study involves:

  • reviewing the decision tool you receive
  • answering a series of questions about how your treatment decision is made
  • describing how helpful you found the decision tool
  • completing additional surveys 3 and 9 months after initial study

Study 2: Intermediate risk prostate cancer – The study is open to men with newly diagnosed intermediate risk prostate cancer. Participation in the study involves:

  • reviewing the decision tool you receive
  • answering a series of questions about how your treatment decision is made
  • describing how helpful you found the decision tool
  • completing additional surveys 3 and 9 months after initial study

Study 3: Prostate cancer survivor – The study seeks men with a history of prostate cancer willing to review a dashboard and give feedback about what works, what doesn’t work, and how the dashboard can be improved. The study is also open to spouses, partners and other immediate family members of men with a history of prostate cancer.